Literature DB >> 30060839

Comparative Neuropathology of Major Indian Bluetongue Virus Serotypes in a Neonatal BALB/c Mouse Model.

A Anjaneya1, K P Singh2, S Cherian3, M Saminathan3, R Singh3, M A Ramakrishnan4, S Maan5, N S Maan5, D Hemadri6, P P Rao7, K Putty8, Y Krishnajyothi9, P P Mertens10.   

Abstract

Bluetongue virus (BTV) is neurotropic in nature, especially in ruminant fetuses and in-utero infection results in abortion and congenital brain malformations. The aim of the present study was to compare the neuropathogenicity of major Indian BTV serotypes 1, 2, 10, 16 and 23 by gross and histopathological lesions and virus distribution in experimentally infected neonatal BALB/c mice. Each BTV serotype (20 μl of inoculum containing 1 × 105 tissue culture infectious dose [TCID]50/ml of virus) was inoculated intracerebrally into 3-day-old mice, while a control group was inoculated with mock-infected cell culture medium. Infection with BTV serotypes 1, 2 and 23 led to 65-70% mortality at 7-9 days post infection (dpi) and caused severe necrotizing encephalitis with neurodegenerative changes in neurons, swelling and proliferation of vascular endothelial cells in the cerebral cortex, cerebellum, midbrain and brainstem. In contrast, infection with BTV serotypes 10 and 16 led to 25-30% mortality at 9-11 dpi and caused mild neuropathological lesions. BTV antigen was detected by immunohistochemistry, direct fluorescence antibody technique and confocal microscopy in the cytoplasm of neuronal cells of the hippocampus, grey matter of the cerebral cortex and vascular endothelial cells in the midbrain and brainstem of BTV-1, -2, -10, -16 and -23 infected groups from 3 to 20 dpi. BTV nucleic acid was detected in the infected brain tissues from as early as 24 h up to 20 dpi by VP7 gene segment-based one-step reverse transcriptase polymerase chain reaction. This study of the relative neurovirulence of BTV serotypes is likely to help design suitable vaccination and control strategies for the disease.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BALB/c mice; bluetongue virus; histopathology; neuropathogenicity

Mesh:

Year:  2018        PMID: 30060839     DOI: 10.1016/j.jcpa.2018.06.001

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  4 in total

1.  Thiamine Deficiency Modulates p38MAPK and Heme Oxygenase-1 in Mouse Brain: Association with Early Tissue and Behavioral Changes.

Authors:  Rita de Cássia Noronha Medeiros; Juliana Oliveira Moraes; Samara Dias Cardoso Rodrigues; Leidiano Martins Pereira; Helen Quézia da Silva Aguiar; Clarissa Amorim Silva de Cordova; Alberto Yim Júnior; Fabiano Mendes de Cordova
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

2.  Thiamine deficiency and recovery: impact of recurrent episodes and beneficial effect of treatment with Trolox and dimethyl sulfoxide.

Authors:  Ketren Carvalho Gomes; Francisco Wanderson Bizerra Lima; Helen Quézia da Silva Aguiar; Suiane Silva de Araújo; Clarissa Amorim Silva de Cordova; Fabiano Mendes de Cordova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-09-01       Impact factor: 3.195

3.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

4.  Pathological and immunological characterization of bluetongue virus serotype 1 infection in type I interferons blocked immunocompetent adult mice.

Authors:  Mani Saminathan; Karam Pal Singh; Madhulina Maity; Sobharani Vineetha; Gundallhalli Bayyappa Manjunathareddy; Kuldeep Dhama; Yashpal Singh Malik; Muthannan Andavar Ramakrishnan; Jyoti Misri; Vivek Kumar Gupta
Journal:  J Adv Res       Date:  2021-01-20       Impact factor: 10.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.